Controlled clinical trials in cystic fibrosis — are we doing better?
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 5 (1) , 3-8
- https://doi.org/10.1016/j.jcf.2005.09.005
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosaJAMA, 2003
- Assessing allocation concealment and blinding in randomised controlled trials: why bother?Evidence-Based Nursing, 2001
- Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and interventionPediatric Pulmonology, 1999
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999
- Bibliometric analysis of randomized trials in complementary medicineComplementary Therapies in Medicine, 1998
- Quality of Full and Final Publications Reporting Acute Stroke TrialsStroke, 1998
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Empirical Evidence of BiasJAMA, 1995
- Statistical aspects of research methodologyBritish Journal of Surgery, 1991